Displaying items by tag: department of neurology

Researchers will delve into the role of inflammation and the immune system in the worsening of Parkinson’s disease as UAB is named a Udall Center of Excellence.
UAB was part of a national, multisite study that showed a drug for multiple sclerosis was effective in slowing down brain atrophy, or shrinkage.
UAB will fill a gap in the stroke belt as it joins StrokeNet, a national research consortium.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
UAB's study of CBD oil for intractable epilepsy, funded by the State of Alabama under Carly's Law, shows that CBD oil reduces seizure frequency and severity in patients with treatment-resistant epilepsy.
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
The body’s autonomic nervous system affects involuntary actions, such as heart beat and breathing, and UAB opens a new tool to help diagnose autonomic-related conditions.
A neuron model of Parkinson’s disease and Lewy body dementias shows defects that could suggest treatments to halt or reverse cognitive impairments before the neurons die.
UAB investigators look at a gene therapy technique that helps cells take out the trash.
New guidelines suggest exercise and cognitive training can help lower the risk of dementia for those with mild cognitive impairment.
UAB will participate in the National Institutes of Health SIREN Network, a series of clinical trials for out-of-hospital medical emergencies.
UAB will examine cognitive behavior therapy, a form of psychotherapy, that may help reduce the severity of non-epileptic seizures induced by traumatic brain injury.
Page 6 of 13